FTRE is now undervalued and could go up 355%
Oct 17, 2025, 12:00 PM
9.46%
What does FTRE do
Fortrea Holdings, headquartered in Durham, North Carolina, provides clinical development and commercialization services, employing 16,000 staff and offering flexible service models globally. The company went public on June 16, 2023.
Based on our analysis, Fortrea Holdings has been assigned an undervalued rating of 4 out of 5 stars by Cashu. This rating is supported by several key financial ratios that indicate the company is performing better than its sector peers in critical areas.
The price-to-book (PB) ratio for Fortrea stands at 1.23, significantly lower than the sector average of 2.71. A lower PB ratio suggests that the stock may be undervalued relative to its assets, indicating potential for price appreciation.
In terms of profitability, Fortrea’s net profit margin is -12.18, compared to the sector's -137.57. This indicates that Fortrea is managing to retain a smaller loss per dollar of revenue compared to its peers, demonstrating better operational efficiency.
Additionally, the return on equity (ROE) for Fortrea is -24.11, which, while negative, is still an improvement over the sector average of -76.41. This suggests that Fortrea is generating more return on shareholders' equity than its competitors, which could lead to a more favorable outlook for future profitability.
Furthermore, Fortrea's return on assets (ROA) ratio is -9.18, again better than the -47.59 sector average. This indicates that the company is utilizing its assets more effectively than others in the industry.
These financial metrics collectively indicate that Fortrea Holdings is undervalued compared to its sector, highlighting its potential for growth and recovery.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
More Signals
Feature in Progress
This section is under development. Check back soon for updates!